UNRESECTABLE MYXOFIBROSARCOMA

Clinical trials for UNRESECTABLE MYXOFIBROSARCOMA explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE MYXOFIBROSARCOMA trials appear

Sign up with your email to follow new studies for UNRESECTABLE MYXOFIBROSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Scientists test Two-Pronged attack on Tough-to-Treat cancers

Disease control Recruiting now

This early-stage study is testing a new combination of two drugs, peposertib and liposomal doxorubicin, for people with advanced soft tissue sarcomas that have spread or cannot be removed by surgery. The main goal is to find the safest and most effective dose of this drug pair. R…

Matched conditions: UNRESECTABLE MYXOFIBROSARCOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 23, 2026 15:14 UTC

UNRESECTABLE MYXOFIBROSARCOMA

Get alerted when new UNRESECTABLE MYXOFIBROSARCOMA trials appear

Scientists test Two-Pronged attack on Tough-to-Treat cancers